Ross Levine is an Oncology physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 1,483 publications with 95,022 citations (h-index 148); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 1% of Hematology / Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1275 York Ave
New York, NY 100656007
Telephone
646-888-2767Registry record last updated 13 Feb 2019.
Clinical trials
- Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia
Sponsor: Eastern Cooperative Oncology Group
- Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- QIAGEN, LLCProgram year20253 payments$122,536openpaymentsdata.cms.gov ↗
- Jubilant Therapeutics IncProgram year20252 payments$30,000openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
13 NIH research awards on record, funded 2007–2026 per NIH RePORTER. The latest:
- Synergistic role of signaling and epigenetics in leukemic transformation
Sloan-Kettering Inst Can Research
FY2026$1,062,000R35CA197594 - Clonal hematopoiesis as a targetable mechanism of resistance to therapy in thyroid cancer.
Sloan-Kettering Inst Can Research
FY2026$752,808R01CA303958 - Project 1: Molecular Pathogenesis and Therapy of Myelofibrosis
Icahn School of Medicine at Mount Sinai
FY2026$453,221P01CA108671
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Valerie Rusch, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”